• Applied Workflows and Innovations with Ciprofloxacin in Rese

  2026-05-19

  Ciprofloxacin's proven role as a fluoroquinolone antibiotic underpins advanced research in antimicrobial resistance, bacterial infection modeling, and multifunctional drug delivery. Recent nanotheranostic breakthroughs and rigorous protocol optimization enable scientists to push the boundaries of DNA replication inhibition studies and therapeutic assay design.

• Calpain Inhibition Restores Offspring Cognition After Matern

  2026-05-18

  This study reveals that excessive calpain activation following maternal non-obstetric surgery disrupts offspring hippocampal development and cognition via BDNF/TrkB pathway dysregulation. Pharmacological inhibition of calpain with MDL 28170 partially rescues neuronal integrity and cognitive performance, highlighting a mechanistic link and therapeutic potential.

• Cell-Surface LAMP1 as a Senescence Marker in Aging and Fibro

  2026-05-18

  This study establishes lysosomal-associated membrane protein 1 (LAMP1) as a robust, cell-surface biomarker of cellular senescence across aging and idiopathic pulmonary fibrosis contexts. The findings enable selective identification and targeting of senescent cells, facilitating both mechanistic research and the development of senolytic strategies.

• Gingerenone A Reverses Sunitinib Resistance in Renal Cancer

  2026-05-17

  This study identifies gingerenone A as a novel inhibitor of LDHA-driven glycolysis in renal cell carcinoma (RCC), restoring sensitivity to the tyrosine kinase inhibitor sunitinib in resistant cancer models. The findings highlight metabolic targeting as a promising strategy for overcoming drug resistance in RCC.

• Annexin V-FITC/PI Apoptosis Assay Kit: Technical Guide

  2026-05-16

  The Annexin V-FITC/PI Apoptosis Assay Kit enables rapid, fluorescence-based detection and discrimination of viable, apoptotic, and necrotic cells, streamlining early apoptosis detection in research settings. This kit is optimal for flow cytometry and fluorescence microscopy workflows but is not validated for diagnostic or medical applications.

• WZ4003 (SKU B1374): Reliable NUAK1/2 Inhibition in Cell Assa

  2026-05-15

  This article addresses real-world laboratory challenges in cell viability, migration, and tau phosphorylation assays, highlighting how WZ4003 (SKU B1374) empowers reproducible, data-driven workflows targeting NUAK1/2. Scenario-based Q&A illuminate best practices, protocol optimization, and vendor selection, grounded in recent literature and validated performance. Explore how WZ4003 can advance your cancer and neurodegeneration research.

• Ciprofloxacin in Advanced Antimicrobial Resistance Workflows

  2026-05-15

  Ciprofloxacin, a benchmark fluoroquinolone antibiotic, empowers researchers to dissect DNA replication inhibition and resistance gene transmission in multidrug-resistant pathogens. This guide translates recent genomic epidemiology into actionable protocols, highlights troubleshooting strategies, and showcases APExBIO's rigorously characterized Ciprofloxacin for reproducible, high-impact results.

• Ceftolozane Sulfate: Advanced Protocols for Antibacterial As

  2026-05-14

  Ceftolozane sulfate empowers translational researchers to design robust, resistance-aware antibacterial workflows targeting Pseudomonas aeruginosa and multidrug-resistant Enterobacterales. This guide details actionable setup, troubleshooting, and optimization strategies that leverage APExBIO's high-purity reagent for reproducible PK/PD studies and in vitro susceptibility testing.

• ApoEVs Drive Metastasis and Stemness in Lung Adenocarcinoma

  2026-05-14

  This study reveals that tumor-derived apoptotic extracellular vesicles (apoEVs) enhance metastasis, self-renewal, and chemoresistance in lung adenocarcinoma by transferring ALDH1A1 and activating SOX2 via the NF-κB pathway. The findings uncover a novel intercellular communication mechanism shaping cancer stemness, with implications for biomarker discovery and therapeutic targeting.

• SD 169 (indole-5-carboxamide): Selective p38 MAPK Inhibitor

  2026-05-13

  SD 169 (indole-5-carboxamide) is a selective, ATP-competitive inhibitor of p38α and p38β MAP kinases. It enables precise inhibition of the p38 MAPK signaling pathway, supporting reproducible research in inflammation, diabetes, and neuroregeneration. Robust evidence demonstrates its efficacy in modulating cellular stress responses and preserving beta cell mass.

• Applied Workflows for SIRT1/2 Inhibitor IV (Cambinol) in CNS

  2026-05-13

  SIRT1/2 Inhibitor IV (cambinol) enables precise dissection of NAD-dependent deacetylase pathways in both cancer and CNS injury models. This article delivers actionable protocols, advanced troubleshooting, and a translation of recent lactylation research into real-world assay strategies.

• 4μ8C: Illuminating IRE1α RNase Inhibition for Translational

  2026-05-12

  This thought-leadership article dissects the strategic and mechanistic value of 4μ8C (7-hydroxy-4-methyl-2-oxochromene-8-carbaldehyde) for translational researchers targeting the unfolded protein response (UPR). By integrating the latest insights on ER stress signaling, selective IRE1α inhibition, and new paradigms in protein degradation, we provide actionable guidance for experimental design and translational strategy in cancer and stress biology.

• Aclacinomycin A: Advancing DNA Damage Research in Oncology

  2026-05-12

  This article provides a translational researcher’s lens on Aclacinomycin A (Aclarubicin), examining its mechanistic roles as a dual topoisomerase and proteasome inhibitor, benchmarking its cytotoxicity, and positioning it within the evolving landscape of DNA damage and apoptosis research. Drawing on recent mechanistic insights, particularly persistent rDNA lesions and PML-nucleolar dynamics, we outline experimental strategies, competitive context, and future perspectives on leveraging Aclacinomycin A in preclinical workflows. This analysis transcends typical product summaries by connecting APExBIO’s offering with actionable, evidence-based guidance and emerging mechanistic paradigms.

• Calpain Inhibitor I, ALLN: Technical Guidance for Research U

  2026-05-11

  Calpain Inhibitor I, ALLN is a potent, selective tool for inhibiting calpain and cathepsin proteases in apoptosis assays and ischemia-reperfusion injury models. It is best applied in mechanistic inflammation research where precise, reversible suppression of protease activity is required. This reagent is not intended for diagnostic or clinical applications.

• MTT for In Vitro Cell Proliferation: Precision Assay Strateg

  2026-05-11

  MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) sets the benchmark for quantifying cell metabolic activity and viability in translational research. Discover optimized workflows, advanced troubleshooting, and actionable insights—empowering robust, reproducible cell-based assays in drug discovery and disease modeling.

456 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page